Citigroup.com Homepage
My Account
Article06 Jun 2024

A prescription for healthcare treasury

The healthcare industry continues its rapid evolution as emerging and disruptive technologies transform the health and wellness space. This in turn is impacting how treasury organizations are supporting strategic objectives. Today’s healthcare industry is more globalized than ever before, leading to an increase in merger and acquisition (M&A) activity, particularly in biopharma, which is projected to see health-tech investments of approximately $1.2 Tn through 2025.

Treasury organizations are under pressure to explore future payment models in order to meet the evolving needs of their businesses.

To learn more about how businesses can navigate their treasury and commercial journeys in this rapidly evolving industry, download the full report to read more.

Subscribe

Sign up to receive our newsletter providing a roundup of recent content and updates on new reports.